Organon & Co.: all 514 studies

Page 3 of 6. Open to participants first (0), then studies with results posted, then the rest; newest registration first within each.

• Placebo-Controlled Study of Mometasone Furoate Nasal Spray (MFNS) 200 mcg QD in the Treatment of Seasonal Allergic Rhinitis (Study P05106)(COMPLETED)CompletedNCT00468312Phase 3Results posted
• A Study to Determine the Number of Patients Who Reach Optimal Cholesterol Levels on Each of Three Different Treatments (0653A-121)CompletedNCT00462748Phase 3Results posted
• Montelukast Back to School Asthma Study (0476-340)CompletedNCT00461032Phase 3Results posted
• Placebo-Controlled Study of Mometasone Furoate Nasal Spray (MFNS) 200 mcg Once Daily (QD) in the Treatment of Seasonal Allergic Rhinitis (Study P05067)(COMPLETED)CompletedNCT00453063Phase 3Results posted
• A Study of Losartan Compared to Losartan/HCTZ in Pediatric Patients With Hypertension (0954A-327)TerminatedNCT00447603Phase 3Results posted
• Vytorin (10/20 Or 10/40) Compared to Atorvastatin (10 mg or 20 mg) in Patients With Coronary Artery Disease (0653A-126)(COMPLETED)CompletedNCT00442897Phase 4Results posted
• Montelukast in Mild Asthmatic Children With Allergic Rhinitis (0476-367)CompletedNCT00442559Phase 4Results posted
• Efficacy and Tolerability of Maintenance Treatment With Asmanex Twisthaler Versus Placebo in Mild/Moderate Persistent Asthmatics (Study P04654)(TERMINATED)TerminatedNCT00442351Phase 4Results posted
• Study of MK-0476 in Adult Patients With Acute Asthma (0476-334)CompletedNCT00442338Phase 3Results posted
• A Comparison of Mometasone Furoate DPI Versus Budesonide DPI in Budesonide DPI in Asthmatics (Study P04880)CompletedNCT00442117Phase 3Results posted
• Study of Inhaled Glucocorticosteroids/Long-Acting Bronchodilator Drugs in Subjects With Asthma That Have Been Taking Inhaled Glucocorticosteroids (Study P04705AM1)CompletedNCT00424008Phase 3Results posted
• The Effects of Ezetimibe/Simvastatin 10/20 mg Versus Simvastatin 40 mg in High Cholesterol and Coronary Heart Disease Study (P04039AM2)(COMPLETED)CompletedNCT00423579Phase 4Results posted
• Ezetimibe and Simvastatin in Primary Hypercholesterolemia, Diabetes Mellitus Type 2, and Coronary Heart Disease (COMPLETED)CompletedNCT00423488Phase 3Results posted
• The Study of Nasonex® Compared With Placebo for the Relief of Symptoms Associated With Acute Bacterial Sinusitis When Used With Antibiotics (Study P04824AM3)TerminatedNCT00423176Phase 3Results posted
• Ezetimibe and Atorvastatin vs. Atorvastatin in Patients Age 65 and Older at High Risk for Coronary Heart Disease (CHD)(0653-112)CompletedNCT00418834Phase 3Results posted
• Effects of Vytorin Versus Placebo in Subjects With Primary Hypercholesterolemia (Study P04420)CompletedNCT00413972Phase 3Results posted
• Efficacy and Safety Study of the Combined Oral Contraceptive NOMAC-E2 Compared to a COC Containing DRSP/EE (292002)(P05722)CompletedNCT00413062Phase 3Results posted
• Ezetimibe/Simvastatin in Patients With Metabolic Syndrome (0653A-107)(COMPLETED)CompletedNCT00409773Phase 3Results posted
• Study for the Treatment of Intermittent Allergic Rhinitis With Desloratadine (Study P04683)CompletedNCT00406783Phase 3Results posted
• Study for the Treatment of Persistent Allergic Rhinitis With Desloratadine (Study P04684)CompletedNCT00405964Phase 3Results posted
• Effects of Mometasone Furoate Dry Powder Inhaler, Fluticasone Propionate, and Montelukast on Bone Mineral Density in Asthmatics (Study P03418)CompletedNCT00394355Phase 4Results posted
• Effects of Mometasone Furoate/Formoterol Combination Versus Formoterol and Mometasone Furoate Alone in Chronic Obstructive Pulmonary Disease (COPD) (Study P04230AM4)(COMPLETED)CompletedNCT00383721Phase 3Results posted
• Effects of Mometasone Furoate/Formoterol Combination Versus Mometasone Furoate Alone in Persistent Asthmatics (Study P04073AM1)(COMPLETED)CompletedNCT00383552Phase 3Results posted
• Effects of Mometasone Furoate/Formoterol Combination Versus Formoterol and Mometasone Furoate Alone in COPD (Study P04229AM4)(COMPLETED)CompletedNCT00383435Phase 3Results posted
• Effects of Mometasone Furoate/Formoterol Combination Versus Mometasone Furoate Alone in Persistent Asthmatics (Study P04334AM1)(COMPLETED)CompletedNCT00383240Phase 3Results posted
• Effects of Mometasone Furoate/Formoterol Combination Versus Mometasone Furoate Alone in Persistent Asthmatics (Study P04431AM2)(COMPLETED)CompletedNCT00381485Phase 3Results posted
• Study of Mometasone Furoate/Formoterol Combination and Fluticasone/Salmeterol in Persistent Asthmatics Previously Treated With Inhaled Glucocorticosteroids (P04139)CompletedNCT00379288Phase 3Results posted
• Study of Nasonex® for the Treatment of Nasal Polyps in Pediatric Subjects Between Ages of 6 and Less Than 18 Years Old (P04292)CompletedNCT00378378Phase 3Results posted
• The Effects of Mometasone Furoate Nasal Spray in Subjects With Sleep-disordered Breathing (SDB) Associated With Perennial Allergic Rhinitis (Study P04726)CompletedNCT00359216Phase 4Results posted
• The Duration of the Suppressive Effects of Desloratadine on Allergen Prick Tests After Discontinuation (P04441)CompletedNCT00359138Phase 4Results posted
• Mometasone Furoate on Sleep Disturbances in Subjects With Seasonal Allergic Rhinitis (Study P04608) (COMPLETED)CompletedNCT00358527Phase 4Results posted
• Intermittent and Daily Dosing for Episodic (Periodic) Asthma (0476-302)(COMPLETED)CompletedNCT00337675Phase 3Results posted
• Adding Ezetimibe Tablet to Ongoing Treatment With Atorvastatin in Subjects With High Cholesterol and Multiple Coronary Heart Disease Risk Factors (Study P04060)(COMPLETED)CompletedNCT00319449Phase 4Results posted
• Obese Hypertension Study (0954-315)CompletedNCT00289887Phase 3Results posted
• Montelukast in Pediatric Allergic Asthma (0476-336)(COMPLETED)CompletedNCT00289874Phase 3Results posted
• Montelukast Asthmatic Smoker Study (0476-332)(COMPLETED)CompletedNCT00284856Phase 3Results posted
• Study of Asenapine in Elderly Subjects With Psychosis (A7501021)(P05717)CompletedNCT00281320Phase 3Results posted
• To Evaluate Ezetimibe Plus Atorvastatin Versus Atorvastatin in Patients With High Cholesterol Not Controlled on Atorvastatin 40 mg (0653-090)CompletedNCT00276484Phase 3Results posted
• To Evaluate Ezetimibe Plus Atorvastatin Versus Atorvastatin in Patients With High Cholesterol Not Controlled on Atorvastatin 20 mg (0653-079)(COMPLETED)CompletedNCT00276458Phase 3Results posted
• The Effects of Phenylephrine Compared With Those of Placebo and Pseudoephedrine on Nasal Congestion in Subjects With Seasonal Allergic Rhinitis (SAR)(P04579)CompletedNCT00276016Phase 3Results posted
• To Evaluate Ezetimibe/Simvastatin and Niacin (Extended Release Tablet) in Patients With Type IIa or Type IIb Hyperlipidemia (0653A-091)(COMPLETED)CompletedNCT00271817Phase 3Results posted
• 6-Month Extension Trial of Asenapine With Olanzapine in Negative Symptom Patients Who Completed the Protocol 25543 (25544)(P05777)CompletedNCT00265343Phase 3Results posted
• Rheumatoid Arthritis Dose Ranging Study (0663-086)(COMPLETED)CompletedNCT00264147Phase 2Results posted
• Study to Test a Marketed Product in the Treatment of Migraine-associated NauseaCompletedNCT00250458Phase 3Results posted
• Montelukast Compared With Placebo and Salmeterol in Exercise-Induced Bronchoconstriction (0476-316)CompletedNCT00245570Phase 3Results posted
• MK0476 Study in Adult Patients With Acute Asthma (0476-322)CompletedNCT00229970Phase 3Results posted
• IMPROVE-IT: Examining Outcomes in Subjects With Acute Coronary Syndrome: Vytorin (Ezetimibe/Simvastatin) vs Simvastatin (P04103)CompletedNCT00202878Phase 3Results posted
• 6-Month Extension Trial of Asenapine With Olanzapine in Negative Symptoms Patients Who Completed the First 6- Month Trial (A7501014)(COMPLETED)(P05772)CompletedNCT00174265Phase 3Results posted
• Ezetimibe Plus (+) Simvastatin Versus Atorvastatin Comparative Study (0653A-092)(COMPLETED)CompletedNCT00166504Phase 4Results posted
• 40 Week Extension Study Of Asenapine and Olanzapine For Bipolar Disorder (A7501007)(COMPLETED)(P05857)CompletedNCT00159783Phase 3Results posted
• Long-Term Efficacy and Safety of Asenapine Using Haloperidol as a Positive Control (41513)(COMPLETED)(P05785)CompletedNCT00156065Phase 3Results posted
• To Determine Long Term Efficacy and Safety of Asenapine in Schizophrenic Patient Population (A7501012)(COMPLETED)(P05770)CompletedNCT00150176Phase 3Results posted
• 40 Week Trial to Study the Safety of Asenapine When Added to Lithium or Valproate in the Treatment of Bipolar Disorder (A7501009)(P05786)CompletedNCT00145509Phase 3Results posted
• Efficacy and Safety of Asenapine Compared With Olanzapine in Patients With Persistent Negative Symptoms of Schizophrenia (A7501013)(COMPLETED)(P05771)CompletedNCT00145496Phase 3Results posted
• 12 Week Study of the Safety/Efficacy of Asenapine When Added to Lithium/Valproate in the Treatment of Bipolar Disorder (A7501008 / P05844 / MK-8274-017)CompletedNCT00145470Phase 3Results posted
• Effects of Ezetimibe With Simvastatin in the Therapy of Adolescents With HeFH (Study P02579)CompletedNCT00129402Phase 3Results posted
• Two Investigational Drugs in the Prevention of Airway Constriction Brought on by Exercise in Participants With Asthma (0476-911)CompletedNCT00127166Phase 3Results posted
• A Study of an Intravenous Drug in Pediatric Patients With Acute Asthma (0476-301)CompletedNCT00117338Phase 3Results posted
• A Study to Evaluate the Effects of Ezetimibe (MK-0653) on the Postprandial (Following a Meal) Lipoprotein Response in Participants With Primary Hypercholesterolemia (High Cholesterol) (MK-0653-072)(COMPLETED)CompletedNCT00101439Phase 3Results posted
• An Investigational Drug on Clinical Outcomes in Patients With Aortic Stenosis (Narrowing of the Major Blood Vessel of the Heart)(MK-0653A-043 AM4)(COMPLETED)CompletedNCT00092677Phase 3Results posted
• Montelukast in Exercise-Induced Bronchospasm - 2003 (0476-270)CompletedNCT00092131Phase 3Results posted
• The Clinical Effects of Montelukast in Patients With Perennial Allergic Rhinitis (0476-265)CompletedNCT00092118Phase 3Results posted
• Study to Evaluate Potential Decrease in Hospitalization Events, Time Between Events, and Increasing Longevity in Patients With Symptomatic Heart Failure (0954-948)CompletedNCT00090259Phase 3Results posted
• Montelukast in Exercise-Induced Bronchospasm - 2004 (0476-275)CompletedNCT00090142Phase 3Results posted
• EARLY ACS: Early Glycoprotein IIb/IIIa Inhibition in Patients With Non-ST-segment Elevation Acute Coronary Syndrome (Study P03684AM2)(COMPLETED)CompletedNCT00089895Phase 3Results posted
• Nasonex Compared With Placebo in Participants With Seasonal Allergic Rhinitis (SAR) and Concomitant Asthma (P03280)CompletedNCT00070707Phase 4Results posted
• A Study to Investigate Safety and Efficacy of Tapinarof Cream, 1% in Participants Ages 3 Months to < 24 Months With Atopic DermatitisSuspendedNCT07265479Phase 3
• Tapinarof for the Treatment of Plaque Psoriasis in Pediatric SubjectsActive, not recruitingNCT05172726Phase 3
• RUBY Post-Market Registry on the Jada® SystemCompletedNCT04995887
• A Relative Bioavailability Study of FOR-6219 in Capsule and Tablet FormulationsCompletedNCT04686669Phase 1
• A Study to Assess Contraceptive Efficacy and Safety of Etonogestrel (ENG) Implant Beyond 3 Years of Use (MK-8415-060)CompletedNCT04626596Phase 3
• Safety and Tolerability Study of Cerdulatinib Gel, 0.37% in Adults With VitiligoCompletedNCT04103060Phase 2
• Safety and Tolerability Study of Ezetimibe (SCH 058235/MK-0653) Plus Atorvastatin or Simvastatin in Homozygous Familial Hypercholesterolemia (P01417/MK-0653-019)CompletedNCT03885921Phase 3
• Ezetimibe (SCH 58235) Taken With Either Atorvastatin or Simvastatin in Participants With Familial Hypercholesterolemia (MK-0653-018)CompletedNCT03884452Phase 3
• A Long-term Safety and Tolerability Study of Ezetimibe Plus Atorvastatin in Participants With Coronary Heart Disease, Multiple Risk Factors, or Hypercholesterolemia Not Controlled by Atorvastatin (P01418/MK-0653-032)CompletedNCT03882996Phase 3
• A Study of SCH 58235 (Ezetimibe) When Added to Ongoing Therapy With a Statin in Participants With Primary Hypercholesterolemia, Known Coronary Heart Disease, or Multiple Cardiovascular Risk Factors (P02173)CompletedNCT03882905Phase 3
• Long-Term Safety and Tolerability of Ezetimibe (SCH 58235, MK-0653) With Atovastatin (P02154, MK-0653-017)CompletedNCT03882892Phase 3
• Efficacy and Safety Study of Ezetimibe (SCH 58235, MK-0653) in Addition to Atorvastatin in Participants With Coronary Heart Disease or Multiple Cardiovascular Risk Factors (P00693/MK-0653-030)CompletedNCT03867318Phase 3
• An Efficacy and Safety Study of Ezetimibe (MK-0653, SCH 58235) in Addition to Atorvastatin Compared to Placebo in Participants With Primary Hypercholesterolemia (MK-0653-013)CompletedNCT03867110Phase 3
• A Study to Investigate the Safety, Tolerability, Food Effect, Pharmacokinetics and Pharmacodynamics of FOR-6219CompletedNCT03709420Phase 1
• Open-Label Study of RVT-501 Topical Ointment in Pediatric Patients With Atopic DermatitisStatus unknownNCT03415282Phase 1
• Study of RVT-501 Topical Ointment in Pediatric Patients With Atopic DermatitisCompletedNCT03394677Phase 2
• Study of RVT-501 in Adult and Adolescent Subjects With Atopic DermatitisCompletedNCT02950922Phase 2
• A Phase 1/2 Study of E6005 in Pediatric Subjects With Atopic DermatitisCompletedNCT02094235Phase 1/2
• Efficacy and Safety of Oral NOMAC-E2 in Indian Women (P07057/MK-8175A-017)WithdrawnNCT01723579Phase 3
• Finasteride (MK-0906) and Male Breast Cancer - A Register-Based Nested Case-Control Study (MK-0906-162/2003.021).CompletedNCT01703520
• Etoricoxib Prescribing Patterns and Adverse Events of Interest in Primary Care in the United Kingdom (MK-0663-162 AM1)CompletedNCT01685424
• Study of the Effect of Mometasone Furoate/Formoterol (MF/F), Montelukast and Beclomethasone Dipropionate (BDP) on Plasma Cortisol Levels of Children 5-11 Years Old With Persistent Asthma (P05574)WithdrawnNCT01615874Phase 2
• An Efficacy and Safety Study of Corifollitropin Alfa (MK-8962) in Contrast to Recombinant FSH for Use in Controlled Ovarian Stimulation of Indian Women (P07056, Also Known as MK-8962-029)WithdrawnNCT01599494Phase 3
• A Study to Evaluate the Efficacy and Safety of Vytorin Versus Standard Treatment of Other Statins in Moderate, Moderately High and High Risk Participants (MK-0653A-406)WithdrawnNCT01587235Phase 4
• An Observational Drug Utilization Study of Asenapine in the United Kingdom (P08308)CompletedNCT01498770
• Post-Authorization Safety Surveillance Study of Asenapine in Participants With Bipolar Disorder (P08307)CompletedNCT01495741
• A Phase 2 Study of E6005 in Patients With Atopic DermatitisCompletedNCT01461941Phase 2
• A Study of Etoricoxib in Participants With Osteoarthritis Not Responding to Analgesic Drugs (MK-0663-142)WithdrawnNCT01429168Phase 4
• A Post Marketing Observational Study of the Safety and Efficacy of Elonva (Corifollitropin Alfa) in General Practice (P08165)CompletedNCT01408615
• Safety of Etoricoxib (MK-0663) in Patients With Spondyloarthropathy (SpA)/Ankylosing Spondylitis (AS) in Sweden (EP07013.013.11.082)CompletedNCT01327638
• Post-Marketing Surveillance of the Safety and Efficacy of Orgalutran (Ganirelix)®CompletedNCT01304511
• A Study to Determine the Bioequivalence of SCH 900068 Compared to Marketed Products (Protocol No. P07551)CompletedNCT01236430Phase 1
• A Study of E6005 in Japanese Patients With Atopic DermatitisCompletedNCT01179880Phase 1/2
• Post-authorization Safety Study of Etoricoxib and Other Anti-inflammatory Therapies in European Patients With Ankylosing Spondylitis (MK-0663-163)CompletedNCT01077843

← Organon & Co. overview and focus areas